Artículos por temáticas

[Alzheimer's disease and care needs: what do nurses know?]

Poltroniere S, Cecchetto FH, de Souza EN.

Rev Gaucha Enferm. 2011 Jun;32(2):270-8. doi: 10.1590/s1983-14472011000200009.

Combined administration of D-galactose and aluminium induces Alzheimer-like lesions in brain

Xiao F, Li XG, Zhang XY, Hou JD, Lin LF, Gao Q, Luo HM.

Neurosci Bull. 2011 Jun;27(3):143-55. doi: 10.1007/s12264-011-1028-2.

Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trial

Kamphuis PJ, Verhey FR, Olde Rikkert MG, Twisk JW, Swinkels SH, Scheltens P.

J Nutr Health Aging. 2011 Aug;15(8):672-6. doi: 10.1007/s12603-011-0339-3.

Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil

Alvarez XA, Cacabelos R, Sampedro C, Couceiro V, Aleixandre M, Vargas M, Linares C, Granizo E, García-Fantini M, Baurecht W, Doppler E, Moessler H.

Curr Alzheimer Res. 2011 Aug;8(5):583-91. doi: 10.2174/156720511796391863.

Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease

Sodhi RK, Singh N, Jaggi AS.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Aug;384(2):115-24. doi: 10.1007/s00210-011-0654-6. Epub 2011 May 24.

Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type

Dhillon S.

Drugs. 2011 Jun 18;71(9):1209-31. doi: 10.2165/11206380-000000000-00000.

Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease

Britton GB, Smith MA, Perry G, Sambamurti K, Jagannatha Rao KS.

J Alzheimers Dis. 2011;24 Suppl 2:1-2. doi: 10.3233/JAD-2011-110021.

Experimental research on nitric oxide and the therapy of Alzheimer disease: a challenging bridge

Siciliano R, Barone E, Calabrese V, Rispoli V, Butterfield DA, Mancuso C.

CNS Neurol Disord Drug Targets. 2011 Nov;10(7):766-76. doi: 10.2174/187152711798072356.

Power and pitfalls of the genome-wide association study approach to identify genes for Alzheimer's disease

Sherva R, Farrer LA.

Curr Psychiatry Rep. 2011 Apr;13(2):138-46. doi: 10.1007/s11920-011-0184-4.

AD: are we intervening too late?

Korczyn AD.

J Neural Transm (Vienna). 2011 Sep;118(9):1359. doi: 10.1007/s00702-011-0702-x.

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

Portelius E, Mattsson N, Andreasson U, Blennow K, Zetterberg H.

Curr Pharm Des. 2011;17(25):2594-602. doi: 10.2174/138161211797416039.

Memory problems in dementia: adaptation and coping strategies and psychosocial treatments

Dröes RM, van der Roest HG, van Mierlo L, Meiland FJ.

Expert Rev Neurother. 2011 Dec;11(12):1769-81; quiz 1782. doi: 10.1586/ern.11.167.

Non-psychiatric comorbidity associated with Alzheimer's disease

Duthie A, Chew D, Soiza RL.

QJM. 2011 Nov;104(11):913-20. doi: 10.1093/qjmed/hcr118. Epub 2011 Jul 18.

When will Alzheimer's disease be cured? A pharmaceutical perspective

Townsend M.

J Alzheimers Dis. 2011;24 Suppl 2:43-52. doi: 10.3233/JAD-2011-110020.

Lack of evidence for the efficacy of memantine in mild Alzheimer disease

Schneider LS, Dagerman KS, Higgins JP, McShane R.

Arch Neurol. 2011 Aug;68(8):991-8. doi: 10.1001/archneurol.2011.69. Epub 2011 Apr 11.